Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT01246999 · ClinicalTrials.gov registry record · Phase 4
Effect of Age and Prior Immunity to Response to Seasonal Influenza Vaccines in Children
A Phase 4 study of Influenza, sponsored by University of Rochester.
- Completed
- Registry status
- Phase 4
- Development phase
- 34
- Enrollment target
- 2
- Study locations
NCT01246999 is a Phase 4 study of Influenza that has completed, run by University of Rochester. The registered enrollment target is 34 participants, below the 36,804-participant average among 156 other Influenza trials with a reported enrollment target (100% lower). The trial reports 2 study locations across 2 states.
The verdict
NCT01246999, a Phase 4 study of Influenza, has completed, sponsored by University of Rochester.
- COMPLETED
- Registry status
- Phase 4
- Development phase
- 34 participants
- Enrollment target
- 2
- Study locations
Study Summary
A total of 88 children between 2 and 9 years of age will be randomized to receive a two dose schedule of either licensed live attenuated trivalent seasonal influenza vaccine (LAIV) or licensed inactivated seasonal influenza vaccine (TIV)or TIV followed by LAIV or LAIV followed by TIV separated by 28 days. Children with a laboratory documented history of prior H1N1 infection will be excluded.
Conditions Studied
Interventions
- BIOLOGICAL Trivalent Influenza Vaccine
- BIOLOGICAL Live attenuated Influenza vaccine
- BIOLOGICAL TIV followed by LAIV
- BIOLOGICAL LAIV followed by TIV
Study Locations (2)
New Hampshire
- Dartmouth-Hitchcock Medical Center - Lebanon
New York
- Vaccine Research Unit Room 3-5000 - Rochester
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 34 participants |
| Start Date | 2010-10 |
| Est. Completion | 2013-06 |
| Phase | Phase 4 |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT01246999
The ClinicalTrials.gov registry entry for NCT01246999 describes a study currently listed as completed, categorized as Phase 4. The registered enrollment target is 34 participants, a figure that helps gauge the scale of data the investigators plan to collect, below the 36,804-participant average among 156 other Influenza trials with a reported enrollment target (100% lower). The listed sponsor is University of Rochester, which has 636 total studies on file at ClinicalTrials.gov.
The record links to 1 condition, with Influenza appearing as the primary indexed condition, and to 4 interventions - of which Trivalent Influenza Vaccine is the first listed.
NCT01246999 reports 2 study locations spanning 2 distinct geographic areas - top geographies include New Hampshire, New York.
Frequently Asked Questions
What is clinical trial NCT01246999 about?
NCT01246999 is a clinical study titled "Effect of Age and Prior Immunity to Response to Seasonal Influenza Vaccines in Children". A total of 88 children between 2 and 9 years of age will be randomized to receive a two dose schedule of either licensed live attenuated trivalent seasonal influenza vaccine (LAIV) or licensed inactivated seasonal influenza vaccine (TIV)or TIV followed by LAIV or LAIV followed by TIV separated by 28...
What is the current status of trial NCT01246999?
This trial is currently completed. It is a Phase 4 study. The enrollment target is 34 participants. The study started on 2010-10. Estimated completion is 2013-06.
What conditions does trial NCT01246999 study?
This clinical trial studies the following conditions: Influenza.
What interventions are being tested in trial NCT01246999?
The interventions under investigation include: Trivalent Influenza Vaccine (BIOLOGICAL), Live attenuated Influenza vaccine (BIOLOGICAL), TIV followed by LAIV (BIOLOGICAL), LAIV followed by TIV (BIOLOGICAL).
Who is sponsoring clinical trial NCT01246999?
This trial is sponsored by University of Rochester, which has 636 total clinical trials registered on ClinicalTrials.gov.
Where is trial NCT01246999 being conducted?
This trial has 2 study locations across New Hampshire, New York. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.
Learn More About Clinical Trials
Similar trials for Influenza
Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.
-
B Cell and Antibody Response to Seasonal Influenza Vaccines in Younger and Older Adults
RECRUITING · Phase 4
-
Comparative Immunogenicity of Respiratory Virus Vaccines (CIRV2) Study
RECRUITING · Phase 4
-
Bone Marrow and Peripheral Blood Immune Responses Study
RECRUITING · Phase 4
-
Safety and Immunogenicity Among Healthy Children Receiving Fluzone® Quadrivalent Influenza Virus Vaccine
COMPLETED · Phase 4
-
A Study to Evaluate the Safety of HIN1 Monovalent Vaccine (MEDI3414) in Children 2 to 17 Years of Age
COMPLETED · Phase 4
-
Safety and Immunogenicity Among Healthy Children Receiving Fluzone® Quadrivalent, Influenza Vaccine
COMPLETED · Phase 4
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.